SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 17, 2003
IBIS TECHNOLOGY CORPORATION
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Massachusetts
-------------
(State or Other Jurisdiction of Incorporation)
0-23150 04-2987600
- --------------------------------------------------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
32 Cherry Hill Drive, Danvers, Massachusetts 01923
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(978) 777-4247
- --------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
Item 5. Other Events.
On October 17, 2003, the Registrant issued a press release announcing the
public offering of 870,000 shares of its common stock. The offering is being
underwritten by CDC Securities. Ibis has granted CDC Securities an option to
purchase up to an additional 130,000 shares of common stock to cover
over-allotments, if any. All of the shares are being offered by Ibis through a
prospectus supplement pursuant to Ibis' shelf registration statement, which was
declared effective by the Securities and Exchange Commission on October 3, 2003.
The information contained in the press release dated October 17, 2003 is
incorporated herein by reference and filed as Exhibit 99.1 hereto. Ibis filed
with the Commission on October 16, 2003 a prospectus supplement, relating to the
issuance and sale of the common stock. In connection with the filing of the
prospectus supplement with the Commission, Ibis is filing the underwriting
agreement relating thereto as Exhibit 1.1 hereto.
The registrant intends to use the net proceeds from the offering of the
shares to fund research and development, capital expenditures, working capital
and general corporate purposes.
Item 7. Financial Statements and Exhibits.
(c) The following exhibits are filed with this report:
Exhibit No. Title
- ----------- -----
1.1 Underwriting Agreement between Registrant and CDC
Securities dated October 16, 2003
99 The Registrant's Press Release dated October 17, 2003
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IBIS Technology Corporation
Dated: October 17, 2003 By: /s/Debra L. Nelson
----------------------------------------------
Debra L. Nelson, Chief Financial Officer
2
EXHIBIT INDEX
Sequential
Exhibit No. Description Page Number
- ----------- ----------- -----------
1.1 Underwriting Agreement between Registrant
and CDC securities dated October 16, 2003 E-2
99 The Registrant's Press Release
dated October 17, 2003 E-19
E-1